386 related articles for article (PubMed ID: 21397665)
81. Synthesis and biological evaluation of kojic acid derivatives containing 1,2,4-triazole as potent tyrosinase inhibitors.
Xie W; Zhang J; Ma X; Yang W; Zhou Y; Tang X; Zou Y; Li H; He J; Xie S; Zhao Y; Liu F
Chem Biol Drug Des; 2015 Nov; 86(5):1087-92. PubMed ID: 25916324
[TBL] [Abstract][Full Text] [Related]
82. Identifying melanogenesis inhibitors from Cinnamomum subavenium with in vitro and in vivo screening systems by targeting the human tyrosinase.
Wang HM; Chen CY; Wen ZH
Exp Dermatol; 2011 Mar; 20(3):242-8. PubMed ID: 21054558
[TBL] [Abstract][Full Text] [Related]
83. Synthesis, molecular docking, dynamic simulations, kinetic mechanism, cytotoxicity evaluation of N-(substituted-phenyl)-4-{(4-[(E)-3-phenyl-2-propenyl]-1-piperazinyl} butanamides as tyrosinase and melanin inhibitors: In vitro, in vivo and in silico approaches.
Raza H; Abbasi MA; Aziz-Ur-Rehman ; Siddiqui SZ; Hassan M; Abbas Q; Hong H; Shah SAA; Shahid M; Seo SY
Bioorg Chem; 2020 Jan; 94():103445. PubMed ID: 31826809
[TBL] [Abstract][Full Text] [Related]
84. Design and synthesis of biphenyl derivatives as mushroom tyrosinase inhibitors.
Bao K; Dai Y; Zhu ZB; Tu FJ; Zhang WG; Yao XS
Bioorg Med Chem; 2010 Sep; 18(18):6708-14. PubMed ID: 20729091
[TBL] [Abstract][Full Text] [Related]
85. Inhibitory effect of ammonium tetrathiotungstate on tyrosinase and its kinetic mechanism.
Park KH; Lee JR; Hahn HS; Kim YH; Bae CD; Yang JM; Oh S; Bae YJ; Kim DE; Hahn MJ
Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1266-70. PubMed ID: 16946532
[TBL] [Abstract][Full Text] [Related]
86. Synthesis and bioactivity of novel isoxazole chalcone derivatives on tyrosinase and melanin synthesis in murine B16 cells for the treatment of vitiligo.
Niu C; Yin L; Nie LF; Dou J; Zhao JY; Li G; Aisa HA
Bioorg Med Chem; 2016 Nov; 24(21):5440-5448. PubMed ID: 27622747
[TBL] [Abstract][Full Text] [Related]
87. A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds.
Liu J; Cao R; Yi W; Ma C; Wan Y; Zhou B; Ma L; Song H
Eur J Med Chem; 2009 Apr; 44(4):1773-8. PubMed ID: 18524420
[TBL] [Abstract][Full Text] [Related]
88. Short-sequence oligopeptides with inhibitory activity against mushroom and human tyrosinase.
Abu Ubeid A; Zhao L; Wang Y; Hantash BM
J Invest Dermatol; 2009 Sep; 129(9):2242-9. PubMed ID: 19440221
[TBL] [Abstract][Full Text] [Related]
89. (E)-2-Cyano-3-(substituted phenyl)acrylamide analogs as potent inhibitors of tyrosinase: A linear β-phenyl-α,β-unsaturated carbonyl scaffold.
Son S; Kim H; Yun HY; Kim DH; Ullah S; Kim SJ; Kim YJ; Kim MS; Yoo JW; Chun P; Moon HR
Bioorg Med Chem; 2015 Dec; 23(24):7728-34. PubMed ID: 26631438
[TBL] [Abstract][Full Text] [Related]
90. Syntheses of hydroxy substituted 2-phenyl-naphthalenes as inhibitors of tyrosinase.
Song S; Lee H; Jin Y; Ha YM; Bae S; Chung HY; Suh H
Bioorg Med Chem Lett; 2007 Jan; 17(2):461-4. PubMed ID: 17064896
[TBL] [Abstract][Full Text] [Related]
91. Design and synthesis of 3,5-diaryl-4,5-dihydro-1H-pyrazoles as new tyrosinase inhibitors.
Zhou Z; Zhuo J; Yan S; Ma L
Bioorg Med Chem; 2013 Apr; 21(7):2156-62. PubMed ID: 23391365
[TBL] [Abstract][Full Text] [Related]
92. Synthesis and biological evaluation of novel 4-hydroxybenzaldehyde derivatives as tyrosinase inhibitors.
Yi W; Cao R; Peng W; Wen H; Yan Q; Zhou B; Ma L; Song H
Eur J Med Chem; 2010 Feb; 45(2):639-46. PubMed ID: 19932528
[TBL] [Abstract][Full Text] [Related]
93. A Potent Tyrosinase Inhibitor, (
Kim CS; Noh SG; Park Y; Kang D; Chun P; Chung HY; Jung HJ; Moon HR
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360412
[TBL] [Abstract][Full Text] [Related]
94. Integrated kinetic studies and computational analysis on naphthyl chalcones as mushroom tyrosinase inhibitors.
Radhakrishnan S; Shimmon R; Conn C; Baker A
Bioorg Med Chem Lett; 2015 Oct; 25(19):4085-91. PubMed ID: 26318997
[TBL] [Abstract][Full Text] [Related]
95. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
[TBL] [Abstract][Full Text] [Related]
96. Anilino-1,4-naphthoquinones as potent mushroom tyrosinase inhibitors:
Sabuakham S; Nasoontorn S; Kongtaworn N; Rungrotmongkol T; Silsirivanit A; Pingaew R; Mahalapbutr P
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2357174. PubMed ID: 38814149
[TBL] [Abstract][Full Text] [Related]
97. Synthesis, characterization and biological evaluation of paeonol thiosemicarbazone analogues as mushroom tyrosinase inhibitors.
Zhu TH; Cao SW; Yu YY
Int J Biol Macromol; 2013 Nov; 62():589-95. PubMed ID: 24120880
[TBL] [Abstract][Full Text] [Related]
98. Thioquinoline derivatives conjugated to thiosemicarbazide as potent tyrosinase inhibitors with anti-melanogenesis properties.
Noori M; Sabourian R; Tasharoie A; Safavi M; Iraji A; Khalili Ghomi M; Dastyafteh N; Irajie C; Zarenezhad E; Mostafavi Pour SM; Rasekh F; Larijani B; Amini M; Hajimahmoodi M; Mahdavi M
Sci Rep; 2023 Feb; 13(1):2578. PubMed ID: 36782003
[TBL] [Abstract][Full Text] [Related]
99. Azepine derivative T4FAT, a new copper chelator, inhibits tyrosinase.
Okajima S; Hamamoto A; Asano M; Isogawa K; Ito H; Kato S; Hirata Y; Furuta K; Takemori H
Biochem Biophys Res Commun; 2019 Jan; 509(1):209-215. PubMed ID: 30579605
[TBL] [Abstract][Full Text] [Related]
100. Design, synthesis and biological evaluation of hydroxy- or methoxy-substituted phenylmethylenethiosemicarbazones as tyrosinase inhibitors.
Yi W; Cao RH; Chen ZY; Yu L; Ma L; Song HC
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1273-7. PubMed ID: 19881280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
